Due to their important contributions to the inflammatory process, several studies have illustrated cytokines benefits in immunotherapy of mastitis via enhancing MG immunity (e.g., interferons, mainly IFN-γ, IL-2) [257–261], their contributions to control or prevention/immunisation against mastitis pathogens especially E. coli or Staph. The gene discussed is IFNG; the disease is mastitis.